SMITHKLINE BEECHAM (EXPORT) LIMITED

Active London

Other business support service activities n.e.c.

0 employees website.com
Other business support service activities n.e.c.
S

SMITHKLINE BEECHAM (EXPORT) LIMITED

Other business support service activities n.e.c.

Founded 8 Oct 1993 Active London, United Kingdom 0 employees website.com
Other business support service activities n.e.c.

Previous Company Names

STERLING HEALTH (EXPORT) LIMITED 29 Dec 1993 — 2 Apr 1996
INTERCEDE 1058 LIMITED 8 Oct 1993 — 29 Dec 1993
Accounts Submitted 29 May 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 8 Sept 2025 Next due 22 Sept 2026 5 months remaining
Net assets £4M £224K 2024 year on year
Total assets £4M £296K 2024 year on year
Total Liabilities £166K £72K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SMITHKLINE BEECHAM (EXPORT) LIMITED (02860752), an active company based in London, United Kingdom. Incorporated 8 Oct 1993. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£4.29M

Increased by £224.00k (+6%)

Total Liabilities

£166.00k

Increased by £72.00k (+77%)

Turnover

N/A

Employees

N/A

Debt Ratio

4%

Increased by 2 (+100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Glaxo Group LimitedCorporate-directorUnited KingdomUnknown14 Mar 2001Active
Michael Sean ReillyDirectorBritishUnited Kingdom5923 Jun 2023Active

Shareholders

Shareholders (1)

Smithkline Beecham Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GSK PLC united kingdom
SMITHKLINE BEECHAM (EXPORT) LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Nov 2025OfficersTermination of Michael Sean Reilly as director on 2025-11-01
13 Nov 2025OfficersAppointment of Dr James Bringloe as director on 2025-11-01
8 Sept 2025Confirmation StatementConfirmation statement made on 2025-09-08 with no updates
29 May 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
29 May 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
13 Nov 2025 Officers

Termination of Michael Sean Reilly as director on 2025-11-01

13 Nov 2025 Officers

Appointment of Dr James Bringloe as director on 2025-11-01

8 Sept 2025 Confirmation Statement

Confirmation statement made on 2025-09-08 with no updates

29 May 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

29 May 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

Recent Activity

Latest Activity

Termination of Michael Sean Reilly as director on 2025-11-01

5 months ago on 13 Nov 2025

Appointment of Dr James Bringloe as director on 2025-11-01

5 months ago on 13 Nov 2025

Confirmation statement made on 2025-09-08 with no updates

7 months ago on 8 Sept 2025

Audit exemption statement of guarantee by parent company for period ending 31/12/24

10 months ago on 29 May 2025

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

10 months ago on 29 May 2025